US FDA begins to address nanotechnology regulatory concerns

In the USA, hundreds of nanotechnology products, including medicines, medical devices and foods, have now reached the market, and their number will grow exponentially in the years ahead. But the main regulating authority, the Food and Drug Administration, is just beginning to address the unique issues presented by this groundbreaking technology, according to an Insighter article, written by Beryl Lieff Benderly, and posted on the Food and Drug Law Institute's web site, at: www.fdli.org.

The future growth opportunities in the nanotechnology sector will lie in pharmaceutical and health care applications of nanotechnologies, according to a report from Cientifica (Marketletter April 30, 2007), which forecast that this will account for some 80% of a global $1,500.0 billion nanotech market by 2015.